Table 1 Baseline characteristics of the patients
Variable | Group A (N = 17) | Group B (N = 23) | P value |
|---|---|---|---|
Number of hips | 22 | 29 | Â |
Age, years | 35.4 ± 11.1 | 39.4 ± 10.4 | 0.252 |
Sex | Â | Â | 0.605 |
 Male | 12 (70.6%) | 19 (82.6%) | |
 Female | 5 (29.4%) | 4 (17.4%) | |
Weight (kg) | 65.6 ± 14.7 | 65.3 ± 7.7 | 0.949 |
Hip involved unilateral | 12 (70.6%) | 17 (73.9%) | 1.000 |
Hip involved bilateral | 5 (29.4%) | 6 (26.1%) | |
Etiology | Â | Â | 0.080 |
 Steroid | 8 (36.4%) | 3 (10.3%) | |
 Alcohol | 5 (22.7%) | 9 (31.1%) | |
 Idiopathic | 9 (40.9%) | 17 (58.6%) | |
Ficat stage | Â | Â | 0.114 |
 Stage I | 1 (4.5%) | 1 (3.4%) | |
 Stage II | 19 (86.4%) | 20 (69.0%) | |
 Stage III | 2 (9.1%) | 6 (20.7%) | |
 Stage IV | 0 (0) | 2 (6.9%) | |
Pain scores | 17.7 ± 4.3 | 17.6 ± 5.1 | 0.917 |
Function scores | 49.5 ± 7.8 | 50.9 ± 9.0 | 0.550 |
Harris Hip Scores | 67.2 ± 9.2 | 68.5 ± 13.1 | 0.678 |